PT  - JOURNAL ARTICLE
AU  - Jeannine W C Blake
AU  - Karen K Giuliano
AU  - Robert D Butterfield
AU  - Tim Vanderveen
AU  - Nathaniel M Sims
TI  - Extending tubing to place intravenous smart pumps outside of patient rooms during COVID-19: an innovation that increases medication dead volume and risk to patients
AID  - 10.1136/bmjinnov-2020-000653
DP  - 2021 Apr 01
TA  - BMJ Innovations
PG  - 379--386
VI  - 7
IP  - 2
4099  - http://innovations.bmj.com/content/7/2/379.short
4100  - http://innovations.bmj.com/content/7/2/379.full
SO  - BMJ Innov2021 Apr 01; 7
AB  - The COVID-19 pandemic has stretched hospitals to capacity with highly contagious patients. Acute care hospitals around the world have needed to develop ways to conserve dwindling supplies of personal protective equipment (PPE) while front-line clinicians struggle to reduce risk of exposure. By placing intravenous smart pumps (IVSP) outside patient rooms, nurses can more quickly attend to alarms, rate adjustments and bag changes with reduced personal risk and without the delay of donning necessary PPE to enter the room. The lengthy tubing required to place IVSP outside of patient rooms comes with important clinical implications which increase the risk to patient safety for the already error-prone intravenous medication administration process. This article focuses on the implications of increasing medication dead volume as intravenous tubing lengths increase. The use of extended intravenous tubing will lead to higher medication volumes held in the tubing which comes with significant safety implications related to unintended alterations in drug delivery. Safe intravenous medication administration is a collaborative responsibility across the team of nurses, pharmacists and ordering providers. This article discusses the importance and safety implications for each role when dead volume is increased due to IVSP placement outside of patient rooms during the COVID-19 pandemic.No data are available.